EUVIMEDEUVIMED entdecken
Open Access

Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant Epilepsy

Jimmy C Yang, Henry Skelton, Faical Isbaine, Katie L Bullinger, Abdulrahman Alwaki, Brian T Cabaniss, Jon T Willie, Robert E Gross

Stereotactic and Functional Neurosurgery · 14.08.2024 · 102 (6) · 345-355

DOI: 10.1159/000540431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stereotactic and Functional Neurosurgery, online erschienen am 14.08.2024. Verfasst von Jimmy C Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA, jimmy.c.yang@gmail.com. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neuromodulation is an important treatment modality for patients with drug-resistant epilepsy who are not candidates for resective or ablative procedures. However, randomized controlled trials and real-world studies reveal that a subset of patients will experience minimal reduction or even an increase in seizure frequency after neuromodulation. We describe our experience with patients who undergo a second intracranial neuromodulation procedure after unsatisfactory initial response to intracranial neuromodulation.

Methods

We performed a retrospective chart review to identify all patients who had undergone deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) or responsive neurostimulation (RNS), followed by additional intracranial neuromodulatory procedures, with at least 12 months of follow-up. Demographic and clinical data, including seizure frequencies, were collected.

Results

All patients had temporal lobe epilepsy. Six patients were treated with concurrent ANT DBS and temporal lobe RNS, and 3 patients transitioned between neuromodulation systems. Of the patients treated concurrently with ANT DBS and temporal lobe RNS, 5 of the 6 patients experienced additional reduction in seizure frequency after adding a second neuromodulation system. Of the patients who switched between neuromodulation modalities, all patients experienced further reduction in seizure frequency.

Conclusions

For patients who do not experience adequate benefit from initial therapy with ANT DBS or temporal lobe RNS, the addition of a neuromodulation system or switching to a different form of neuromodulation may allow for additional reduction in seizure frequency. Larger studies will need to be performed to understand whether the use of multiple systems concurrently leads to improved clinical results in patients who are initially treatment resistant to neuromodulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDrug Resistant EpilepsyHumansFemaleMaleAdultRetrospective StudiesTreatment OutcomeMiddle AgedYoung AdultEpilepsy, Temporal LobeAnterior Thalamic NucleiFollow-Up StudiesCombined Modality Therapy

Stichwörter der Autor:innen

Deep brain stimulationEpilepsyNeuromodulationResponsive neurostimulation

Autor:innen und Institutionen

  • Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA, jimmy.c.yang@gmail.com.
  • Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA, jimmy.c.yang@gmail.com.
  • Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA.

Förderung

  • NINDS NIH HHS

Zitieren

APA

Yang, J. C., Skelton, H., Isbaine, F., Bullinger, K. L., Alwaki, A., Cabaniss, B. T., Willie, J. T., & Gross, R. E. (2024). Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant Epilepsy. Stereotactic and Functional Neurosurgery, 102(6), 345-355. https://doi.org/10.1159/000540431

Vancouver

Yang JC, Skelton H, Isbaine F, Bullinger KL, Alwaki A, Cabaniss BT, et al. Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant Epilepsy. Stereotactic and Functional Neurosurgery. 2024;102(6):345-355. doi:10.1159/000540431

BibTeX
@article{Yang2024,
  author = {Yang, Jimmy C and Skelton, Henry and Isbaine, Faical and Bullinger, Katie L and Alwaki, Abdulrahman and Cabaniss, Brian T and Willie, Jon T and Gross, Robert E},
  title = {Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant Epilepsy},
  journal = {Stereotactic and Functional Neurosurgery},
  year = {2024},
  volume = {102},
  number = {6},
  pages = {345--355},
  doi = {10.1159/000540431}
}
Kostenlos starten →